Getinge (OTCMKTS:GNGBY) Shares Gap Up – Here’s Why

Getinge (OTCMKTS:GNGBY) shares gapped up prior to trading on Friday . The stock had previously closed at $21.53, but opened at $24.18. Getinge shares last traded at $24.18, with a volume of 107 shares trading hands.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Getinge to a “hold” rating in a report on Thursday, April 23rd. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

Getinge Price Performance

The company’s fifty day moving average is $20.57 and its 200 day moving average is $21.32. The firm has a market cap of $6.59 billion, a price-to-earnings ratio of 26.28 and a beta of 0.96. The company has a quick ratio of 0.86, a current ratio of 1.32 and a debt-to-equity ratio of 0.27.

Getinge (OTCMKTS:GNGBY) last issued its quarterly earnings results on Friday, July 17th. The company reported $0.38 earnings per share (EPS) for the quarter. Getinge had a net margin of 6.92% and a return on equity of 10.39%. On average, equities research analysts predict that Getinge will post 1.26 EPS for the current year.

About Getinge

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.